BRIDGET NOORISHAD: Open Payments
NPI 1073295143 · LYNNWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 38 payments from 17 companies in 2025. Trend: 2023 $70 · 2024 $1,009 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $145 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| ABBVIE INC. | 3 | $69 |
| Novo Nordisk Inc | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Kowa Pharmaceuticals America, Inc. | 2 | $57 |
| Exact Sciences Corporation | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Hologic Sales and Service, LLC | 1 | $32 |
Products named: M-M-R II, FARXIGA, ZORYVE, PREVNAR 20, Cologuard Collection Kit, ELIQUIS, AJOVY, Wegovy.
Industry payments across WA — which companies pay providers there.
